Sunday, September 19, 2010

Google Alert - health

News5 new results for health
 
BRCA1 Breast Cancer Risk Linked to Other Mutations
MedPage Today
By Charles Bankhead, Staff Writer, MedPage Today Discuss with interested patients that a recent genetic study indicates that five specific chromosomal abnormalities associated with one region on chromosome 19 appear to distinguish BRCA1 gene carriers ...
See all stories on this topic »
Spiriva is an alternative for adult asthmatics, researchers say
Los Angeles Times
By Thomas H. Maugh II, Los Angeles Times Spiriva, a drug that is already widely used to treat chronic obstructive pulmonary disease, can provide significant relief of symptoms for adult asthmatics who have difficulty obtaining relief with other drugs, ...
See all stories on this topic »
No Biological Father, High Income Spawns Early Puberty in Girls
eMaxHealth
Researchers find that some girls enter puberty early when no biological father is present in the home. The link was especially strong in African American households with absent fathers. The findings have scientists speculating as to the reasons, ...
See all stories on this topic »
Some provisions in healthcare reform law take effect on Sept 23
Food Consumer
Data provided by the United States Census Bureau show that 50.7 million American did not have health insurance in 2009, an increase of 4.4 million when compared to 2008, according to the White House. Nancy Ann Deparle, director of the White House ...
See all stories on this topic »
New drug that kills deadly superbugs in less than 5 minutes
Times of India
LONDON: British scientists claim to have achieved a major breakthrough by developing a drug which could kill deadly superbugs like C-diff and MRSA. C-Diff or Clostridium difficile is a life-threatening bacterium that causes diarrhoea and intestinal ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Remove this alert.
Create another alert.
Manage your alerts.

No comments:

Post a Comment